Drawing for PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS

USPTO serial 99469347

PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS

Reviewed by CopyMark Law Group

Reg. 8498690Status 700Registered
Filing date
Status date
Registration date
Oct 13, 2026
Examiner
SHERMAN, GENEVA R
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PEDIATRIC TRIALS NETWORK MAKING DRUGS SAFER & MORE EFFECTIVE FOR USE IN THE YOUNGEST PATIENTS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William B. Cannon

William B. Cannon Parker Poe Adams & Bernstein LLP301 Fayetteville Street, Suite 1400Raleigh, NC 27601United States

Goods and services

ClassDescriptionStatusFirst use
042Medical research; Pharmaceutical research services; Research and development in the field of medications and medical devices for use in pediatric patients; Clinical research in the field of development of medications and medical devices for use in pediatric patients; Medical and scientific research, namely, conducting clinical trials for others; Consulting services for others in the field of design, planning, and implementation project management of pediatric clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trialsACTIVESep 30, 2011

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 13, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 13, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 25, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 25, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 19, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 30, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 28, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 28, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 28, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 27, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 27, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 27, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 9, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 9, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 9, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 24, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 13, 2026DOCKASSIGNED TO EXAMINER—
Mar 11, 2026MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Mar 11, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 29, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 29, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance